
About Rynel Clifton Pharma Private Limited
Data last updated:
Rynel Clifton Pharma Private Limited is a private limited company based in Hisar, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110HR2013PTC049548. Its GSTIN is 06AAGCR6535E1ZF (Haryana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajiv Chawla and Ashwini Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dss 65 Commercial Complex Kaimary Road Sector – 15A, Hisar, Haryana, India – 125001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.68 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹4.31 Lakh (net margin 1.6%) and EBITDA of ₹5.92 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
As per MCA filings, the company has open charges of ₹23 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rynelcliftonpharma.com.
Company details
Contact details
Rynel Clifton Pharma Private Limited's registered office is in Hisar, Haryana. Its website is rynelcliftonpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDss 65 Commercial Complex Kaimary Road Sector – 15A, Hisar, Haryana, India – 125001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rynel Clifton Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rynel Clifton Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rynel Clifton Pharma Private Limited, buy the company report.
Financials of Rynel Clifton Pharma Private Limited
FY 2025 filings availableRynel Clifton Pharma Private Limited reported revenue of ₹2.68 Cr (down 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rynel Clifton Pharma Private Limited, buy the company report.
Board of directors of Rynel Clifton Pharma Private Limited
Rynel Clifton Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Chawla Also directs: Eyeris Vision Care Private Limited | Director | 14 Jun 2013 | 13 Years 5 Months | Current |
| Ashwini Kumar Also directs: Grevis Pharmaceuticals Private Limited | Director | 14 Jun 2013 | 13 Years 5 Months | Current |
Peer comparison
Rynel Clifton Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medicure Formulations Private Limited | ₹2.69 Cr (FY 2025) | 22.0% | Thane, Maharashtra, India | |||
| Conset Pharma Private Limited | ₹2.69 Cr (FY 2024) | -11.0% | Indore, Madhya Pradesh, India | |||
| Rynel Clifton Pharma Private Limitedthis company | ₹2.68 Cr (FY 2024) | ₹4.31 Lakh | 1.6% | -12.0% | Hisar, Haryana, India | |
| Synoglad Pharmaceuticals Private Limited | ₹2.67 Cr (FY 2016) | 8.0% | Jaipur, Rajasthan, India | |||
| SRK Life Sciences & Research (India) Private Limited | ₹2.67 Cr (FY 2024) | 13.0% | Mangalore, Karnataka, India | |||
| Medcare Marketing Private Limited | ₹2.67 Cr (FY 2022) | 1.0% | Kochi, Kerala, India |
To see the full peer comparison of Rynel Clifton Pharma Private Limited, buy the company report.
Auditor
Rynel Clifton Pharma Private Limited is audited by BHAVUK DHAMIJA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHAVUK DHAMIJA & ASSOCIATES | FY 2021 | 029151N |
Shareholding
The shareholding of Rynel Clifton Pharma Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Rynel Clifton Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Dec 2014 | 10543500 | State Bank of India | ₹23 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Rynel Clifton Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rynel Clifton Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rynel Clifton Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAGCR6535E1ZF | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rynel Clifton Pharma Private Limited, buy the company report.
Recent activity
Rynel Clifton Pharma Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Ashwini Kumar was appointed as Director on 14 Jun 2013.
Frequently asked questions
Rynel Clifton Pharma is an active private limited company based in Hisar, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 June 2013 (13+ years old) and is registered under CIN U33110HR2013PTC049548.
Rynel Clifton Pharma has 2 current directors:
- Rajiv Chawla - Director
- Ashwini Kumar - Director
The latest financial statements of Rynel Clifton Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rynel Clifton Pharma is 06AAGCR6535E1ZF, registered in Haryana.
The CIN (Corporate Identification Number) of Rynel Clifton Pharma is U33110HR2013PTC049548. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rynel Clifton Pharma was incorporated on 14 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rynel Clifton Pharma by revenue are Medicure Formulations Private Limited, Conset Pharma Private Limited, Synoglad Pharmaceuticals Private Limited, SRK Life Sciences & Research (India) Private Limited, Medcare Marketing Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ashwini Kumar was appointed as Director on 14 Jun 2013. Rajiv Chawla was appointed as Director on 14 Jun 2013.
Rynel Clifton Pharma can be reached through the website rynelcliftonpharma.com. Its registered office is in Hisar, Haryana, India.
The registered office of Rynel Clifton Pharma is at Dss 65 Commercial Complex Kaimary Road Sector – 15A, Hisar, Haryana, India – 125001.
Rynel Clifton Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

